Charlie Strange

Future Plans and Next Steps

Vaughn Edelson, Sharon F. Terry, James O'Leary, 2010 .

[Table, Demonstration Project].

Vaughn Edelson, Sharon F. Terry, Ilana Harlow, 2010 .

[Table, Community Snapshot].

Vaughn Edelson, Sharon F. Terry, Ilana Harlow, 2010 .

Cyclophosphamide versus placebo in scleroderma lung disease.

Charlie Strange, Robert Simms, Jonathan Goldin, 2006, The New England journal of medicine.

Serum VEGF-D a concentration as a biomarker of lymphangioleiomyomatosis severity and treatment response: a prospective analysis of the Multicenter International Lymphangioleiomyomatosis Efficacy of Sirolimus (MILES) trial.

Charlie Strange, Joel Moss, Yoshikazu Inoue, 2013, The Lancet. Respiratory medicine.

Scleroderma lung disease: "if you don't know where you are going, any road will take you there".

Charlie Strange, C. Strange, J. Seibold, 2008, American journal of respiratory and critical care medicine.

Infection in the intensive care unit: a clinician's view of the role of imaging.

Charlie Strange, C. Strange, 2007, Seminars in roentgenology.

An official American Thoracic Society clinical practice guideline: the clinical utility of bronchoalveolar lavage cellular analysis in interstitial lung disease.

Charlie Strange, Marjolein Drent, Paola Rottoli, 2012, American journal of respiratory and critical care medicine.

Design of the Endobronchial Valve for Emphysema Palliation Trial (VENT): a non-surgical method of lung volume reduction

Geoffrey McLennan, Charlie Strange, Jonathan Goldin, 2007, BMC pulmonary medicine.

IL10 polymorphisms are associated with airflow obstruction in severe alpha1-antitrypsin deficiency.

Charlie Strange, Edwin K Silverman, James K Stoller, 2008, American journal of respiratory cell and molecular biology.